Facebook
Twitter
LinkedIn
Forward
Facebook
X
LinkedIn
ForwardSuicide Prevention: Risk Evaluation and Prevention
An overview of suicide prevention topics relevant to clinical practice. It will include current and upcoming changes to clinical suicide prevention policy, suicide screening recommendations, Common Cause Analysis findings, current TJC guidelines, DHA inspection findings, and the 2024 VA/DoD Clinical Practice Guidelines for suicide prevention. Additionally, the session will provide an overview of the tiered Postvention Response System policy that is being rolled out across the military. The interactive session will provide an opportunity for clinicians to raise questions and challenges with adherence to policy requirements.
Virtual, via Microsoft Teams
Col John Batka. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Dr. Ramya Sundararaman. Presenter has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Disclosure: DHA J-7 staff, planners, authors, faculty, and content reviewers for this educational activity have no relevant financial or non-financial relationship(s) with ineligible companies to disclose.
Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Feb 6, 2026.
Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.
Accommodations: Please contact the course instructor to inquire about accommodations. For additional accommodation requests and/or technical support, email [email protected].
Required Hardware/software